Who we are
Cutanos GmbH is a biotech company founded in 2021 focussing on the development of antigen-specific vaccines and new treatments for autoimmune disorders. Cutanos uses a modular and highly flexible drug delivery system called the Langerhans Cell Targeted Delivery System (LC-TDS). With this technology, we aim to realize innovative immunotherapies in conjunction with minimally invasive administration."
Why/How are we going Green
As a biotechnology lab we feel responsible to not only contribute to science but also carrying out experiments in a more sustainable fashion. Hence, we want to participate in Green Labs Austria vision to reduce plastic waste and our carbon footprint.